Maternal serum levels of total activin-A in first-trimester trisomy 21 pregnancies

被引:12
|
作者
Spencer, K
Liao, AW
Skentou, H
Ong, CYT
Nicolaides, KH
机构
[1] Harold Wood Hosp, Dept Clin Biochem, Endocrine Unit, Romford RM3 0BE, Essex, England
[2] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London SE5 8RX, England
关键词
prenatal screening; Down syndrome; inhibin; free beta-hCG; PAPP-A;
D O I
10.1002/pd.53
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Maternal serum total activin-A concentration was measured in 45 pregnancies affected by trisomy 21 and il 93 control unaffected pregnancies at 10-14 weeks of gestation. In the trisomy 21 pregnancies total activin-A concentration was significantly higher (1.36 MoM of the unaffected pregnancies) and in 16% of cases the level was above the 95th centile of normal. The log(10) SD for the control group and the trisomy 21 group were 0.17 and 0.22. respectively. The median pregnancy associated plasma protein-A (PAPP-A) in this trisomy 21 series was 0.49 and for free beta -hCG was 2.05. In the trisomy group there were significant positive associations between total activin-A and PAPP-A (0.6071) and free beta -hCG (0.4255). The low median difference and the high overlap in values between trisomic and unaffected pregnancies make total activin-A of little practical use in first-trimester screening for trisomy 21. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:270 / 273
页数:4
相关论文
共 50 条
  • [31] Prospective validation of first-trimester combined screening for trisomy 21
    Kagan, K. O.
    Etchegaray, A.
    Zhou, Y.
    Wright, D.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2009, 34 (01) : 14 - 18
  • [32] First trimester levels of inhibins and activin A in normal and failing pregnancies
    Wallace, EM
    Marjono, B
    Tyzack, K
    Tong, S
    CLINICAL ENDOCRINOLOGY, 2004, 60 (04) : 484 - 490
  • [33] Performance of first trimester screening for Trisomy 21 in twin pregnancies
    Bergstrand, Eva
    Borregaard Miltoft, Caroline
    Tabor, Ann
    PRENATAL DIAGNOSIS, 2021, 41 (02) : 210 - 217
  • [34] The effect of maternal obesity and lipid profile on first-trimester serum progesterone levels
    Bartha, Irene
    Joumady, Insaf
    Cuerva, Marcos
    Bartha, Jose Luis
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2023, 5 (07)
  • [35] Maternal serum analyte levels after first-trimester multifetal pregnancy reduction
    Shulman, LP
    Phillips, OP
    Cervetti, TA
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (03) : 1072 - 1074
  • [36] TERMINATION OF FIRST-TRIMESTER PREGNANCIES
    WAY, S
    LANCET, 1974, 2 (7887): : 1017 - 1017
  • [37] First-trimester serum markers combined with maternal characteristics to predict pregnancies at risk of preterm birth
    Stout, Molly
    Goetzinger, Katherine
    Tuuli, Methodius
    Cahill, Alison
    Macones, George
    Odibo, Anthony
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 206 (01) : S184 - S184
  • [38] First trimester maternal serum placental growth factor levels in twin pregnancies
    Cowans, Nicholas J.
    Spencer, Kevin
    PRENATAL DIAGNOSIS, 2013, 33 (13) : 1260 - 1263
  • [39] First trimester levels of maternal serum hCG and inhibin A in pregnancies affected by fetal trisomy 18: a faster trial study.
    Lambert-Messerlian, G
    Canick, J
    Malone, F
    Porter, F
    Nyberg, D
    Comstock, C
    Saade, G
    Berkowitz, R
    Gross, S
    Dugoff, L
    Craigo, S
    Timor, I
    Carr, S
    Wolfe, H
    D'Alton, M
    GENETICS IN MEDICINE, 2004, 6 (04) : 276 - 276
  • [40] First-Trimester Contingent Screening for Trisomy 21 by Fetal Nuchal Translucency and Maternal Serum Biomarkers and Maternal Blood Cell-Free DNA Testing
    Younesi, Sarang
    Savad, Shahram
    Ghafouri-Fard, Soudeh
    Taheri-Amin, Mohammad Mahdi
    Saadati, Pourandokht
    Jamali, Soudabeh
    Balvayeh, Payam
    Delshad, Saeed
    Navidpour, Fariba
    Adiban, Farzaneh
    Amidi, Saloomeh
    Modarressi, Mohammad Hossein
    JOURNAL OF FETAL MEDICINE, 2018, 5 (03) : 139 - 143